NORTH CAROLINA– Global Lyme Diagnostics (GLD) is excited to announce that Dr. Bernarda Zenker has joined GLD’s Scientific Advisory Board.
Global Lyme Diagnostics’ sole mission is to service the dire, unmet needs of our global Lyme community with a new diagnostic solution specific to Lyme Disease that is grounded in science and designed to significantly decrease the number of patients being misdiagnosed.
Dr. Zenker is a Board-Certified Family Physician through the American Academy of Family Medicine and is also Board-Certified in Integrative Medicine. Dr. Zenker has a particular concern for finding solutions to chronic health problems. She utilizes traditional medicine assisted with nutritional supplements and diet recommendations in the treatment and prevention of chronic diseases such as Lyme.
Through her 20 years of family practice experience, Dr. Zenker has become a trusted advisor to physicians across the country and has given hundreds of consultations on various medical matters including diagnosing and treating Lyme disease.
“We are very excited to have Dr. Zenker join our Scientific Advisory Board. Her clinical advice will be extremely valuable in furthering GLD’s science to help the global Lyme community,” stated Mickey Ramchandani, CEO of GLD. “Misdiagnosis is a core issue, as Lyme Disease can masquerade as many things – juvenile arthritis, fibromyalgia, chronic fatigue syndrome, multiple sclerosis and a host of other diseases. We are passionate about providing a diagnostic solution that decreases the misdiagnosis of Lyme Disease.”
About Global Lyme Diagnostics
Patients that would like to request a kit to take to their clinicians can do so here. Note: The GLD Test is not yet available for PA or NY residents. More information about GLD, including the science behind the new test and the GLD team is available at the website at https://glymedx.com.